Abstract: An example of an implantable neuromodulation device includes a bioabsorbable electrode and an elongate bioabsorbable support structure carrying the electrode. The support structure is configured to expand in a direction perpendicular to its length so as to move the electrode into contact with a wall of a naturally occurring lumen of a human patient. The electrode is electrically activatable to modulate a nerve within tissue at or otherwise proximate to the wall of the lumen. An example of a neuromodulation method using the neuromodulation device includes locating the neuromodulation device at a treatment site within the lumen and deploying the neuromodulation device into an expanded treatment state at the treatment site. The method further includes reducing obstruction of blood flow through the lumen after deploying the neuromodulation device and then wirelessly energizing the electrode from an extracorporeal energy source.

Abstract: A catheter includes an elongate shaft including a proximal portion and a distal portion extending from the proximal portion to a distal opening at a distal end of the shaft. The proximal portion defines a proximal guidewire lumen and has a first outer diameter. The distal portion defines a distal guidewire lumen in communication with the proximal guidewire lumen and has a second outer diameter smaller than the first outer diameter. A pressure sensor is coupled to the proximal portion such that the pressure sensor faces the proximal guidewire lumen. When the catheter is tracked to a treatment site within the vasculature, the pressure sensor is disposed proximal the treatment site, the distal opening is disposed distal to the treatment site, and the distal guidewire lumen fills with blood such that the pressure sensor senses a pressure of the blood at the distal end of the shaft.

Abstract: A market-based labeling system and method provides tools to assist a user in accurately generating labels. The system includes a processor-based device, such as a computer, that has associated input/output devices, such as a keyboard and a display. The processor-based device also includes a user-friendly labeling application, which may be implemented as a set of instructions to be executed by the processor. The labeling application may guide the user through a series of steps to produce a set of labels. The labeling application preferably generates the user interfaces and a file that may be viewed, edited, saved and/or printed on an associated printer. The labeling application may include one or more modules, each module being geared toward labels for a particular market. This labeling application tool may run on a general purpose processor, such as a computer, and may interface with general purpose labeling software.

Abstract: A location and retention component is provided for positively locating an overspeed guard and retaining a centrifugal actuator at an optimum positional relationship relative to each other. The system includes a first and second retention element removably engagable to the output shaft of a motor and axially fixable to the shaft at corresponding locations to maintain the optimum positional relationship. The first retention element serves as a positive stop for assembling the overspeed guard on the motor shaft, while the second retention element ensures that the centrifugal actuator is properly placed within the overspeed guard.

Abstract: A catheter is disclosed for providing pressure measurements at a vascular lesion. The catheter includes an outer component having a side opening the providing transverse access to a lumen thereof and an inner component slidably disposed within the lumen. The inner component has a guidewire lumen with a proximal side port. When the inner component is longitudinally translated relative to the outer component, the side port of the inner component is accessible through the side opening of the outer component for providing transverse access to a guidewire. A first pressure sensor is disposed proximate of a distal end of the outer component and a second pressure sensor is disposed proximate of a distal end of the inner component, such that relative longitudinal translation between the inner and outer components permits a distance between the first and second pressure sensors to be varied.

Abstract: Embodiments hereof relate to methods and systems for determining a pressure gradient across a lesion of a vessel without requiring the use of a pharmacological hyperemic agent. A measurement system includes at least an injection catheter and a pressure-sensing instrument or guidewire slidingly disposed through the catheter, the pressure-sensing guidewire including at least one pressure sensor configured to obtain a pressure measurement for use in determining the pressure gradient across the lesion. The catheter is configured to deliver or inject a non-pharmacological fluid, such as saline or blood, across the lesion in order to increase a flow rate there-through, thereby simulating hyperemia without the use of a pharmacological hyperemic agent. Once an increased flow rate that simulates hyperemia is achieved, the pressure sensor of the pressure-sensing guidewire may be utilized to measure the pressure gradient across the lesion in order to assess the severity of the lesion.

Abstract: Devices, systems, and methods for the selective positioning of an intravascular ultrasound neuromodulation device are disclosed herein. One aspect of the present technology is directed to positioning systems for focused ultrasound devices. Some embodiments, for example, are directed to dual-balloon positioning systems. Such systems can include, for example, an elongated shaft and a therapeutic assembly and a balloon assembly carried by a distal portion of the elongated shaft. The therapeutic assembly is configured for delivery within a blood vessel. The balloon assembly can include a first balloon and a second balloon circumferentially offset from the first balloon about the elongated shaft. The first and second balloons can be selectively inflated to position an ultrasound transducer of the therapeutic assembly at a precise location within the blood vessel.

Abstract: Some embodiments include a method of providing a semiconductor device. The method can include: (a) providing a flexible substrate; (b) depositing at least one layer of material over the flexible substrate, wherein the deposition of the at least one layer of material over the flexible substrate occurs at a temperature of at least 180° C.; and (c) providing a diffusion barrier between a metal layer and an a-Si layer. Other embodiments are disclosed in this application.

Abstract: Assemblies, systems, and methods for intravascular neuromodulation include a method of positioning a treatment device and a track element at a treatment site in an artery of a human patient and transforming the track element from a delivery configuration to a deployed configuration to form a spiral-shaped track tending to be in apposition with an inner wall of the artery. The treatment device has a distally-located neuromodulation element for sliding along the spiral-shaped track. The method can also include delivering energy via the neuromodulation element across the inner wall of a renal artery to heat or otherwise electrically modulate neural fibers that contribute to renal function.

Abstract: Medical devices for positioning a valve in a subject's body, such as a prosthetic heart valve in a subject's heart, are disclosed. The prosthetic heart valve may include a valve assembly, a frame, and a control arm. The prosthetic heart valve may include a commissural post or multiple commissural posts. The prosthetic heart valve may include a positional marker on a control arm. The prosthetic heart valve may include multiple positional markers on one or more control arms. The positional markers can be shapes, characters, or other symbols. The positional markers may themselves be asymmetric. The positional markers may be placed in an asymmetric location on a control arm. The control arm may be asymmetrically shaped.

Abstract: Delivery systems for delivering medical devices and prosthetic heart valves in a patient's body are disclosed. The delivery system may include a catheter-based delivery system. The delivery system may include a tip, a capsule, an inner sheath, and a projection. The delivery system may include an outer sheath and a handle. The delivery system may be configured to be actuated via an actuator disposed on the handle. The projection may include an arm portion and a feeler portion. The feeler portion may include an indentation. The delivery system may be configured to correctly position a medical device or prosthetic heart valve.

Abstract: In one aspect, a medical device has a first configuration and a second configuration, a reservoir containing a therapeutic agent, and a barrier layer disposed over the reservoir, wherein the barrier layer comprises an inorganic material. In another aspect, a medical device has a reservoir containing a therapeutic agent, a barrier layer disposed over the reservoir, wherein the barrier layer comprises an inorganic material, and a swellable material disposed between the barrier layer and a surface of the medical device, wherein the swellable material is a material that swells upon exposure to an aqueous environment. In yet another aspect, a medical device has a multi-layered coating having alternating reservoir layers and barrier layers, and a plurality of excavated regions penetrating through at least a partial thickness of the multi-layered coating.

Abstract: The disclosed technology generally relates photovoltaic devices, and more particularly to methods of fabricating heterojunction interdigitated back contact photovoltaic cells having interdigitated emitter regions and back surface field regions.

Abstract: An implantable medical device for releasing therapeutic agent having a medical device body and a plurality of reservoir-defining structures disposed on a surface of the body. A reservoir can be defined by the reservoir-defining structures and therapeutic agent may be located in the reservoir. A cover may extend over the reservoir so that the therapeutic agent is released from the reservoir when the medical device implanted. Methods for making the medical device may also include providing a medical device body, positioning a plurality of reservoir-defining structures on a surface of the body to form a reservoir, loading therapeutic agent into the reservoir, and covering the reservoir so that the therapeutic agent may release when the medical device is implanted. Alternatively, the reservoir may be covered with a cover and an opening formed in the cover so that the therapeutic agent may release when the medical device is implanted.

Abstract: Medical devices, particularly stents, suitable for drug delivery and including a porous structure and/or colors are disclosed.

Abstract: Medical devices having a plurality of nanoparticles disposed over a surface of the medical device. The nanoparticles have a core comprising a therapeutic agent and a shell surrounding the core, wherein the shell comprises a metal. A barrier layer is disposed over the nanoparticles. The barrier layer is water-permeable and comprises a metal that may be different from the metal used in the nanoparticle shells. In certain embodiments, the metal in the barrier layer undergoes galvanic corrosion. Also disclosed are medical device having a reservoir containing a therapeutic agent, with nanoparticles and a barrier layer being disposed over the reservoir; and medical devices having multiple barrier layers and multiple reservoirs containing therapeutic agents.

Abstract: Digital media content from files, streaming data, broadcast data, optical disks, or other storage devices can be linked to Internet information. Identifiers extracted from the media content can be used to direct Internet searches for more information related to the media content.

Abstract: Some embodiments include a method of providing a semiconductor device. The method can include: (a) providing a flexible substrate; (b) depositing at least one layer of material over the flexible substrate, wherein the deposition of the at least one layer of material over the flexible substrate occurs at a temperature of at least 180° C.; and (c) providing a diffusion barrier between a metal layer and an a-Si layer. Other embodiments are disclosed in this application.

Abstract: A bioerodible endoprosthesis erodes to a desirable geometry that can provide, e.g., improved mechanical properties or degradation characteristics.

Abstract: A method of inhibiting a viral infection of a host comprising administering to the host an anti-viral griffithsin polypeptide comprising SEQ ID NO: 3 or a fragment thereof comprising at least eight contiguous amino acids, a nucleic acid encoding the anti-viral polypeptide, or an antibody to the anti-viral polypeptide. A method of inhibiting a virus in a sample comprising contacting the sample with an anti-viral griffithsin polypeptide or antibody thereto also is provided.